The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
Fingers crossed zoom
And how many can we make? Not much according to current share price. Is the market wrong?
Not sure why you think FDA would have any different effect than HUA. We need news on sales and capacity
Complete silence from the BOD and a 'crazy' shorter (Jupiter) working to ensure that the price sits at this level.
Complete speculation but could be talks in the background with Jupiter working on behalf of interested buyer. May explain the complete silence from AS and the BOD - which at this point is inexcusable.
The future potential here certainly looks much, much brighter than it did pre HUA.
Would it have been too much risk for Medusa to start producing prior to HUA landing? Would he great to sell multi months worth of production straight off the bat.
Doesn't the successful HUA open path towards utilising the UK Gov installed equipment?
Could be the reason for odx rise.
For Avacta, potential for 30m immediate supply.
Sovereign test ready to go.....
The really good news it that global governments must now realise that they need to protect against this ever happening again - Omicron has secured testing I think for many years.
The really good news it that global governments must now realise that they need to protect against this ever happening again - Omicron has secured testing I think for many years.
NDN - that's a real stretch to think that the gov would have the nous to think...
This Gov bet against there ever being another lock down. How stupid and irresponsible. If they had stuck with daily testing as was planned and supported by Cummings, we would not be in this position (shutting down over xmas period with $$$$$ huge cost to the economy)
We are run by idiots. Will they make the same mistake again? Surely not!
How It Works
The MeduFlow® test from Medusa19 is the first British designed and manufactured test to obtain a home use CE mark. MeduFlow® is lateral flow test (LFT) using a simple and comfortable anterior nasal swab to qualitatively detect the SARS-CoV-2 antigen. The product provides results on the spot in 20 minutes.
MeduFlow® contains unique and proprietary Affimer® technology from Avacta creating synthetic antibodies to create more binding sites for the virus, leading to excellent sensitivity and specificity.
MeduFlow® is validated against the delta variant, and Medusa19 are constantly monitoring all emerging variants to ensure continued diagnostic accuracy.
Have tried to remain away from this BB during these dark few months. Great news today and I can feel the excitement returning.
It has not been discussed often, but medusa are focused on creating a global business to consumer self testing business, with vision far beyond Covid testing. With self test approval now in place for Covid, I believe that follow on tests will be forthcoming and the approval process much shorter.
Markets such as the US will see huge long term demand for various consumer self testing tests, due to the low solution cost vs seeing a Dr, thus a really exciting new market is opening which David Wilson discussed recently (decentralised testing)
A good day for Investors.
Had a few beers...
The LFT is fooked, forget it and Covid. There's plenty more that Affimers offer and the silence from Avacta is telling.
Nice, very nice!
It has taken far longer than anyone imagined but capacity is ramping up in the background and is DEMAND DRIVEN, per guidance from AS.
Clearly, as is evident with this new variant, Covid is far from behind us... In fact, unless the entire world vacinates to deliver herd immunity (which is years and years away, perhaps never possible) a decent demand for high quality tests will be around forever! Cha ching for avct. Patience will be rewarded here.
Definitely leaky.
Looking string again today. Buys now at 7.6. Should move quickly from here
8s incoming..
Hopefully some truth with the medusa Chinese connection..
China has postponed the Beijing marathon until further notice, amid a surge in coronavirus infections.
It comes as the country's top health official warned that a fresh outbreak of cases is expected to spread further.
China has reported more than 133 cases across 11 provinces so far. All of them have been linked to the highly transmissible Delta variant.
The latest surge is considered the largest outbreak in the country since Nanjing in August this year.
It has raised concerns over China's ability to maintain its zero-tolerance approach to the virus, especially leading up to the 2022 Winter Olympics.
Rns or no rns, it'll be interesting to view the trading activity today.
The majors are certainly printing more free cash than they have done for many years.
Speculate to accumulate as they say.
Long termers will understand.
Looking very perky today. Significant volume of trades that I've not seen for a long time.
I'd love to see a last minute partner come into the mix